Yipinhong (stock symbol 300723.SZ): Received registration certificate for tannase injection.

Zhijun Finance and Economics APP News, One Red (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the injection of xantofean. Indications for xantofean injection include: acute spasm pain caused by digestive system and biliary dysfunction; acute spasmatic urethra, bladder, and kidney colic; gynecological spasmatic pain.